vs
Side-by-side financial comparison of QUALYS, INC. (QLYS) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $175.3M, roughly 1.7× QUALYS, INC.). QUALYS, INC. runs the higher net margin — 30.3% vs 12.8%, a 17.5% gap on every dollar of revenue. On growth, QUALYS, INC. posted the faster year-over-year revenue change (10.1% vs -6.4%). Over the past eight quarters, QUALYS, INC.'s revenue compounded faster (9.6% CAGR vs 4.2%).
Qualys, Inc. is an American technology firm based in Foster City, California, specializing in cloud security, compliance and related services.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
QLYS vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $175.3M | $295.9M |
| Net Profit | $53.1M | $38.0M |
| Gross Margin | 83.4% | 64.6% |
| Operating Margin | 33.6% | 18.4% |
| Net Margin | 30.3% | 12.8% |
| Revenue YoY | 10.1% | -6.4% |
| Net Profit YoY | 20.9% | 68.3% |
| EPS (diluted) | $1.47 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $175.3M | $295.9M | ||
| Q3 25 | $169.9M | — | ||
| Q2 25 | $164.1M | $317.0M | ||
| Q1 25 | $159.9M | $316.2M | ||
| Q4 24 | $159.2M | $297.0M | ||
| Q3 24 | $153.9M | $289.5M | ||
| Q2 24 | $148.7M | $306.1M | ||
| Q1 24 | $145.8M | $303.4M |
| Q4 25 | $53.1M | $38.0M | ||
| Q3 25 | $50.3M | — | ||
| Q2 25 | $47.3M | $-17.7M | ||
| Q1 25 | $47.5M | $22.6M | ||
| Q4 24 | $44.0M | $34.9M | ||
| Q3 24 | $46.2M | $33.6M | ||
| Q2 24 | $43.8M | $40.6M | ||
| Q1 24 | $39.7M | $49.1M |
| Q4 25 | 83.4% | 64.6% | ||
| Q3 25 | 83.6% | — | ||
| Q2 25 | 82.4% | 62.7% | ||
| Q1 25 | 81.9% | 67.9% | ||
| Q4 24 | 81.8% | 65.3% | ||
| Q3 24 | 81.3% | 63.2% | ||
| Q2 24 | 82.2% | 66.4% | ||
| Q1 24 | 81.3% | 67.4% |
| Q4 25 | 33.6% | 18.4% | ||
| Q3 25 | 35.3% | — | ||
| Q2 25 | 31.3% | -7.5% | ||
| Q1 25 | 32.4% | 12.2% | ||
| Q4 24 | 31.0% | 16.0% | ||
| Q3 24 | 29.2% | 13.8% | ||
| Q2 24 | 32.3% | 15.0% | ||
| Q1 24 | 30.7% | 22.1% |
| Q4 25 | 30.3% | 12.8% | ||
| Q3 25 | 29.6% | — | ||
| Q2 25 | 28.8% | -5.6% | ||
| Q1 25 | 29.7% | 7.1% | ||
| Q4 24 | 27.6% | 11.7% | ||
| Q3 24 | 30.0% | 11.6% | ||
| Q2 24 | 29.4% | 13.3% | ||
| Q1 24 | 27.2% | 16.2% |
| Q4 25 | $1.47 | $0.24 | ||
| Q3 25 | $1.39 | — | ||
| Q2 25 | $1.29 | $-0.11 | ||
| Q1 25 | $1.29 | $0.14 | ||
| Q4 24 | $1.19 | $0.22 | ||
| Q3 24 | $1.24 | $0.21 | ||
| Q2 24 | $1.17 | $0.26 | ||
| Q1 24 | $1.05 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $250.3M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $561.2M | $2.0B |
| Total Assets | $1.1B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $250.3M | $172.9M | ||
| Q3 25 | $225.3M | — | ||
| Q2 25 | $194.0M | $162.2M | ||
| Q1 25 | $290.7M | $140.7M | ||
| Q4 24 | $232.2M | $177.5M | ||
| Q3 24 | $235.4M | $187.5M | ||
| Q2 24 | $281.2M | $152.9M | ||
| Q1 24 | $273.8M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $561.2M | $2.0B | ||
| Q3 25 | $529.4M | — | ||
| Q2 25 | $508.2M | $1.9B | ||
| Q1 25 | $498.0M | $2.0B | ||
| Q4 24 | $477.1M | $2.1B | ||
| Q3 24 | $449.6M | $2.1B | ||
| Q2 24 | $427.8M | $2.1B | ||
| Q1 24 | $404.2M | $2.0B |
| Q4 25 | $1.1B | $2.5B | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $999.5M | $2.6B | ||
| Q1 25 | $996.5M | $2.6B | ||
| Q4 24 | $973.5M | $2.7B | ||
| Q3 24 | $908.3M | $2.7B | ||
| Q2 24 | $876.6M | $2.7B | ||
| Q1 24 | $861.8M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.7M | — |
| Free Cash FlowOCF − Capex | $74.9M | — |
| FCF MarginFCF / Revenue | 42.8% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | 1.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | $304.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.7M | — | ||
| Q3 25 | $90.4M | — | ||
| Q2 25 | $33.8M | $98.2M | ||
| Q1 25 | $109.6M | $41.1M | ||
| Q4 24 | $47.7M | $84.3M | ||
| Q3 24 | $61.0M | $63.9M | ||
| Q2 24 | $49.8M | $75.5M | ||
| Q1 24 | $85.5M | $81.0M |
| Q4 25 | $74.9M | — | ||
| Q3 25 | $89.5M | — | ||
| Q2 25 | $32.4M | $93.3M | ||
| Q1 25 | $107.5M | $31.0M | ||
| Q4 24 | $41.9M | $77.5M | ||
| Q3 24 | $57.6M | $54.7M | ||
| Q2 24 | $48.8M | $57.5M | ||
| Q1 24 | $83.5M | $64.5M |
| Q4 25 | 42.8% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 19.8% | 29.4% | ||
| Q1 25 | 67.3% | 9.8% | ||
| Q4 24 | 26.3% | 26.1% | ||
| Q3 24 | 37.4% | 18.9% | ||
| Q2 24 | 32.8% | 18.8% | ||
| Q1 24 | 57.2% | 21.3% |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.8% | 1.5% | ||
| Q1 25 | 1.3% | 3.2% | ||
| Q4 24 | 3.7% | 2.3% | ||
| Q3 24 | 2.2% | 3.2% | ||
| Q2 24 | 0.7% | 5.9% | ||
| Q1 24 | 1.4% | 5.4% |
| Q4 25 | 1.42× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 2.31× | 1.82× | ||
| Q4 24 | 1.09× | 2.42× | ||
| Q3 24 | 1.32× | 1.90× | ||
| Q2 24 | 1.14× | 1.86× | ||
| Q1 24 | 2.15× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
QLYS
| Sales Channel Through Intermediary | $88.6M | 51% |
| Sales Channel Directly To Consumer | $86.7M | 49% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
